IE00B3WMTH43
IE00B3WMTH43
Invesco Health Care S&P US Select Sector UCITS ETF Acc
Loading chart...
Holdings & Portfolio Structure
Holdings as of 09/13/2026Detailed breakdown of ETF components
Synthetic Replication Note (Swap ETF)
Synthetic (Swap)The reported holdings, valuation ratios (P/E, etc.), and analyst estimates reflect the fund's underlying collateral/substitute basket, not the actual composition of the tracked index.
This ETF replicates index returns using financial derivatives (total return swaps) with counterparty banks. For regulatory reasons, the fund maintains a physical collateral basket which often consists of completely different securities than the benchmark index. While price performance accurately tracks the benchmark, fundamentals, sector weights, and individual holdings represent this collateral basket.
All Holdings
# | Ticker | Name | Sector | Industry | Market Cap | Weight | P/E | Fwd P/E | D/E | P/B | P/S | EV/EBITDA | P/FCF | FCF Yield | Revenue Estimate | EPS Estimate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 938,15 Mrd. € | 16.00% | 39.26 | 24.76 | 162.07% | 31.03 | 13.19 | 26.10 | 94.99 | 1.05% | FY Cur +35.78% (28) Q Cur +27.08% (14) FY Next +15.65% (28) Q Next +4.56% (15) | FY Cur +47.76% (27) Q Cur +15.31% (17) FY Next +33.16% (27) Q Next +24.20% (17) | |
| 2 | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 562,31 Mrd. € | 10.70% | 29.71 | 21.26 | 57.71% | 7.41 | 6.43 | 18.54 | 37.31 | 2.68% | FY Cur +7.66% (12) Q Cur +5.84% (10) FY Next +7.04% (11) Q Next +4.27% (9) | FY Cur +2.70% (12) Q Cur -10.55% (11) FY Next +10.97% (11) Q Next +17.44% (10) | |
| 3 | AbbVie Inc. | Healthcare | Drug Manufacturers - General | 436,04 Mrd. € | 7.80% | 78.10 | 17.01 | - | - | 7.59 | 17.74 | 28.96 | 3.45% | FY Cur +10.53% (24) Q Cur +9.79% (18) FY Next +8.80% (23) Q Next +5.55% (17) | FY Cur +39.85% (26) Q Cur +104.02% (18) FY Next +16.25% (25) Q Next +2.24% (17) | |
| 4 | UnitedHealth Group Incorporated | Healthcare | Healthcare Plans | 303,86 Mrd. € | 6.40% | 23.86 | 16.78 | 69.21% | 3.49 | 0.76 | 14.33 | 14.03 | 7.13% | FY Cur -0.11% (19) Q Cur -1.48% (18) FY Next +2.96% (21) Q Next -0.23% (17) | FY Cur +21.51% (25) Q Cur +42.11% (23) FY Next +13.81% (26) Q Next -49.33% (23) | |
| 5 | Merck & Company, Inc. | Healthcare | Drug Manufacturers - General | 320,6 Mrd. € | 5.40% | 115.56 | 15.62 | 128.41% | 8.57 | 5.40 | 13.79 | 23.68 | 4.22% | FY Cur +3.18% (24) Q Cur +0.29% (16) FY Next +4.39% (24) Q Next -3.04% (15) | FY Cur -70.07% (26) Q Cur -17.59% (18) FY Next +246.78% (25) Q Next -8.23% (18) | |
| 6 | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 217,15 Mrd. € | 3.60% | 35.42 | 23.86 | 80.58% | 4.62 | 5.25 | 23.82 | 39.01 | 2.56% | FY Cur +7.45% (25) Q Cur +7.45% (19) FY Next +5.15% (25) Q Next +8.03% (17) | FY Cur +9.90% (26) Q Cur +10.59% (21) FY Next +9.72% (27) Q Next +13.49% (19) | |
| 7 | Amgen Inc. | Healthcare | Drug Manufacturers - General | 200,18 Mrd. € | 3.50% | 25.77 | 16.94 | 490.28% | 19.19 | 5.89 | 15.27 | 25.94 | 3.85% | FY Cur +5.98% (31) Q Cur +5.15% (24) FY Next +3.62% (31) Q Next +2.19% (23) | FY Cur +5.47% (33) Q Cur +2.21% (27) FY Next +6.29% (33) Q Next +0.71% (27) | |
| 8 | Abbott Laboratories | Healthcare | Medical Devices | 154,83 Mrd. € | 3.10% | 31.82 | 16.42 | 63.21% | 3.37 | 3.72 | 16.97 | 24.06 | 4.16% | FY Cur +13.25% (27) Q Cur +14.30% (24) FY Next +8.62% (27) Q Next +4.21% (23) | FY Cur +7.12% (27) Q Cur +8.86% (23) FY Next +9.94% (27) Q Next +15.52% (22) | |
| 9 | Gilead Sciences, Inc. | Healthcare | Drug Manufacturers - General | 167,29 Mrd. € | 2.80% | - | 15.24 | 223.47% | 15.86 | 6.15 | 13.95 | 19.19 | 5.21% | FY Cur +4.36% (25) Q Cur +0.17% (20) FY Next +6.57% (24) Q Next +4.63% (17) | FY Cur -105.06% (27) Q Cur -11.85% (22) FY Next +2503.59% (26) Q Next -0.10% (20) | |
| 10 | Pfizer, Inc. | Healthcare | Drug Manufacturers - General | 143,86 Mrd. € | 2.40% | 37.21 | 9.76 | 74.25% | 1.89 | 2.53 | 8.30 | 12.91 | 7.75% | FY Cur -0.56% (25) Q Cur -4.56% (16) FY Next -3.69% (25) Q Next +6.07% (15) | FY Cur -7.85% (25) Q Cur -14.52% (17) FY Next -2.32% (25) Q Next -4.84% (17) | |
| 11 | CVS Health Corporation | Healthcare | Healthcare Plans | 98,35 Mrd. € | 2.30% | 22.67 | 10.10 | 95.50% | 1.38 | 0.27 | 10.48 | 13.64 | 7.33% | FY Cur +3.97% (21) Q Cur +1.88% (18) FY Next +2.87% (22) Q Next +2.06% (18) | FY Cur +19.15% (25) Q Cur +2.58% (23) FY Next +6.11% (26) Q Next -23.66% (23) | |
| 12 | Bristol-Myers Squibb Company | Healthcare | Drug Manufacturers - General | 107,78 Mrd. € | 2.20% | 13.02 | 8.96 | 201.86% | 5.41 | 2.46 | 8.22 | 14.88 | 6.72% | FY Cur +3.49% (25) Q Cur +3.95% (20) FY Next -3.02% (25) Q Next -0.11% (19) | FY Cur +10.73% (27) Q Cur -5.15% (21) FY Next -3.08% (27) Q Next +3.55% (21) | |
| 13 | Danaher Corporation | Healthcare | Diagnostics & Research | 137,91 Mrd. € | 2.10% | 38.77 | 23.64 | 52.97% | 2.94 | 6.15 | 21.97 | 35.73 | 2.80% | FY Cur +7.26% (23) Q Cur +8.37% (19) FY Next +8.09% (23) Q Next +15.68% (17) | FY Cur +9.09% (25) Q Cur +1.39% (20) FY Next +9.29% (25) Q Next +34.80% (20) | |
| 14 | Intuitive Surgical, Inc. | Healthcare | Medical Instruments & Supplies | 133,67 Mrd. € | 2.10% | 48.62 | 35.00 | - | 8.26 | 13.57 | 33.88 | 57.27 | 1.75% | FY Cur +16.80% (31) Q Cur +16.04% (25) FY Next +12.83% (31) Q Next +10.50% (24) | FY Cur +20.95% (27) Q Cur +10.03% (24) FY Next +12.14% (27) Q Next +7.69% (24) | |
| 15 | Stryker Corporation | Healthcare | Medical Devices | 94,94 Mrd. € | 2.00% | 28.74 | 16.61 | 64.39% | 4.43 | 4.12 | 16.03 | 25.89 | 3.86% | FY Cur +8.34% (27) Q Cur +9.46% (25) FY Next +8.61% (27) Q Next +20.24% (24) | FY Cur +9.86% (28) Q Cur +11.66% (25) FY Next +11.52% (28) Q Next +43.99% (24) | |
| 16 | Vertex Pharmaceuticals Incorpor | Healthcare | Biotechnology | 115,31 Mrd. € | 2.00% | 29.71 | 25.23 | 9.77% | 6.38 | 10.26 | 23.86 | 49.17 | 2.03% | FY Cur +10.45% (16) Q Cur +11.16% (13) FY Next +9.84% (16) Q Next +3.20% (14) | FY Cur -11.12% (16) Q Cur -115.38% (13) FY Next +23.62% (16) Q Next +721.48% (14) | |
| 17 | Medtronic plc. | Healthcare | Medical Devices | 101,01 Mrd. € | 1.90% | 21.74 | 13.79 | 55.37% | 2.25 | 3.01 | 12.70 | 20.91 | 4.78% | FY Cur +7.30% (27) Q Cur +5.82% (23) FY Next +3.65% (27) Q Next +0.45% (22) | FY Cur +8.08% (29) Q Cur -2.07% (24) FY Next +7.33% (29) Q Next +6.92% (23) | |
| 18 | McKesson Corporation | Healthcare | Medical Distribution | 97,69 Mrd. € | 1.80% | 25.16 | 18.56 | - | - | 0.27 | 16.69 | 16.09 | 6.21% | FY Cur +7.05% (12) Q Cur +6.61% (11) FY Next +6.89% (12) Q Next +2.97% (11) | FY Cur +14.25% (14) Q Cur +9.28% (13) FY Next +13.22% (14) Q Next +2.46% (13) | |
| 19 | Elevance Health, Inc. | Healthcare | Healthcare Plans | 79,88 Mrd. € | 1.40% | 18.27 | 13.95 | 68.95% | 1.99 | 0.45 | 9.69 | 20.78 | 4.81% | FY Cur -0.58% (12) Q Cur -1.84% (11) FY Next +1.93% (11) Q Next -2.02% (10) | FY Cur -10.09% (22) Q Cur -22.26% (19) FY Next +8.65% (22) Q Next -48.13% (19) | |
| 20 | The Cigna Group | Healthcare | Healthcare Plans | 66,61 Mrd. € | 1.30% | 11.68 | 8.43 | 74.29% | 1.75 | 0.26 | 7.77 | 9.35 | 10.69% | FY Cur +4.57% (16) Q Cur +3.88% (13) FY Next +4.07% (16) Q Next +2.94% (13) | FY Cur +2.25% (24) Q Cur -4.13% (23) FY Next +9.75% (24) Q Next -1.10% (22) | |
| 21 | Regeneron Pharmaceuticals, Inc. | Healthcare | Biotechnology | 68,6 Mrd. € | 1.20% | 18.46 | 12.11 | 8.54% | 2.36 | 4.95 | 14.58 | 25.07 | 3.99% | FY Cur +20.31% (25) Q Cur +20.96% (19) FY Next +7.56% (23) Q Next +8.04% (18) | FY Cur +27.56% (27) Q Cur +35.49% (22) FY Next -10.42% (9) Q Next +11.61% (21) | |
| 22 | Boston Scientific Corporation | Healthcare | Medical Devices | 55,27 Mrd. € | 1.10% | 17.30 | 12.63 | 50.15% | 2.48 | 2.95 | 12.83 | 25.26 | 3.96% | FY Cur +5.56% (26) Q Cur +1.09% (23) FY Next +4.77% (27) Q Next +5.57% (21) | FY Cur +6.43% (26) Q Cur +0.50% (23) FY Next +3.86% (26) Q Next +10.83% (21) | |
| 23 | HCA Healthcare, Inc. | Healthcare | Medical Care Facilities | 89,31 Mrd. € | 1.10% | 15.12 | 14.09 | - | - | 1.28 | 9.54 | 26.77 | 3.74% | FY Cur +3.87% (23) Q Cur +0.90% (21) FY Next +3.91% (23) Q Next +2.66% (21) | FY Cur +4.50% (23) Q Cur -4.43% (20) FY Next +8.58% (23) Q Next +20.91% (20) | |
| 24 | Cencora, Inc. | Healthcare | Medical Distribution | 55,16 Mrd. € | 1.00% | 24.04 | 16.35 | 446.52% | 20.26 | 0.19 | 13.19 | 30.24 | 3.31% | FY Cur +4.89% (12) Q Cur +4.97% (9) FY Next +4.59% (7) Q Next +1.98% (5) | FY Cur +11.74% (14) Q Cur +19.07% (11) FY Next +10.76% (9) Q Next +0.65% (8) | |
| 25 | Cardinal Health, Inc. | Healthcare | Medical Distribution | 49,1 Mrd. € | 0.90% | 32.86 | 16.90 | - | - | 0.22 | 14.34 | 11.58 | 8.64% | FY Cur +4.53% (15) Q Cur +3.91% (11) FY Next +6.05% (15) Q Next +2.67% (11) | FY Cur +14.74% (17) Q Cur +15.40% (14) FY Next +11.88% (17) Q Next +6.10% (14) |
Results: 59
Weight 16%
Market Cap €938.15B
P/E 39.3
Fwd P/E 24.8
Weight 10.7%
Market Cap €562.31B
P/E 29.7
Fwd P/E 21.3
Weight 7.8%
Market Cap €436.04B
P/E 78.1
Fwd P/E 17.0
Weight 6.4%
Market Cap €303.86B
P/E 23.9
Fwd P/E 16.8
Weight 5.4%
Market Cap €320.6B
P/E 115.6
Fwd P/E 15.6
Weight 3.6%
Market Cap €217.15B
P/E 35.4
Fwd P/E 23.9
Weight 3.1%
Market Cap €154.83B
P/E 31.8
Fwd P/E 16.4
Weight 2.8%
Market Cap €167.29B
P/E -
Fwd P/E 15.2
Weight 2.4%
Market Cap €143.86B
P/E 37.2
Fwd P/E 9.8
Weight 2.3%
Market Cap €98.35B
P/E 22.7
Fwd P/E 10.1
Weight 2.2%
Market Cap €107.78B
P/E 13.0
Fwd P/E 9.0
Weight 2.1%
Market Cap €137.91B
P/E 38.8
Fwd P/E 23.6
Weight 2.1%
Market Cap €133.67B
P/E 48.6
Fwd P/E 35.0
Weight 2%
Market Cap €94.94B
P/E 28.7
Fwd P/E 16.6
Weight 2%
Market Cap €115.31B
P/E 29.7
Fwd P/E 25.2
Weight 1.9%
Market Cap €101.01B
P/E 21.7
Fwd P/E 13.8
Weight 1.8%
Market Cap €97.69B
P/E 25.2
Fwd P/E 18.6
Weight 1.4%
Market Cap €79.88B
P/E 18.3
Fwd P/E 13.9
Weight 1.3%
Market Cap €66.61B
P/E 11.7
Fwd P/E 8.4
Weight 1.2%
Market Cap €68.6B
P/E 18.5
Fwd P/E 12.1
Weight 1.1%
Market Cap €55.27B
P/E 17.3
Fwd P/E 12.6
Weight 1.1%
Market Cap €89.31B
P/E 15.1
Fwd P/E 14.1
Weight 0.9%
Market Cap €49.1B
P/E 32.9
Fwd P/E 16.9
Results 1 - 25 of 59
Per page:
Page 1 / 3